Ms. Nataliya Deych is Chair of the MedTech Europe Middle East and Africa Working Group and Vice President, Regulatory Affairs EMEACLA at Edwards Lifesciences.

Based in the Geneva–Lausanne region of Switzerland, she holds a Master’s degree in Biotechnology and leads the development and implementation of regulatory strategies across Europe, the Middle East, Africa, Latin America and Canada. In her current role, she guides the organisation through evolving regulatory environments and capability investments, with a particular focus on regulatory and clinical pathways for marketing authorisation and patient access. Her work also covers risk-benefit approaches to clinical evidence and Real-World Evidence, particularly for therapies addressing unmet medical needs.

Prior to joining Edwards Lifesciences, Ms. Deych served as Senior Director, Regulatory Affairs EMEA at Medtronic and led Regulatory Affairs at Colgate-Palmolive Europe Sàrl in Basel, Switzerland. Earlier in her career, she held management positions across Research & Development, Manufacturing Process Management and Quality Assurance at Unilever. She has also worked as an independent consultant to the cosmetics industry, including in the area of alternative toxicological methods.